Indication intelligence, analysis and sector perception

Disclosures Supporting Reporting

May 16, 2013 8:40pm

Please see our multiple ... legal disclaimers within this disclosure section in the news portal or web site and/or on the last page of each company review or update. The information contained herein is based on sources believed to be reliable.

Most or many of the subscribers to the RegMedinvestors, RMi or its afiliate Scimitar Equity, LLC want or need an independent view of early or mid-stage regenerative medicine. stem cell or cell therapy <healthcare and/or life sciences> companies whose securities typically involve a higher degree of risk and market volatility than the securities of more established companies. The sector specific company securities discussed in these reviews or updates could and may be unsuitable for some investors depending on their specific investment objectives, financial situation or needs.

RMi's opinion and reviews are NOT recommendations or solicitations for investors to purchase or sell any securities but ... reflect our OPINION at any given time and even those are subject to change based on the ... vagaries of these companies within these markets,

Obtaining Current Disclosures

Applicable current disclosures can be downloaded from our website, by calling the telephone number listed below, or by writing to the address listed below:

Scimitar Equity, LLC
14 Nicholas Road
Hopkinton, Ma 01748
617-559-1080
hwm@regmedinvestors.com
www.regmedinvestors.com

35 companies, 1 interpreter!

Insight, foresight and recommendation

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.